Pharma, Biotech and Generics Industry News | The Pharmaletter
WEBGenerics. 9 September 2024 A significant drop has been noticed in the prices of active pharmaceutical ingredients (APIs), bringing much-needed relief to the pharmaceutical industry and potentially translating to lower drug costs for consumers. 5 September 2024 Amid an explosion in investment and development milestones seen over the past decade ...
Pharmaceutical Industry News | The Pharmaletter
WEBAug 20, 2024 · MHRA finds no evidence to support a link between GLP-1s and suicidal thoughts. MHRA has concluded that the available evidence does not establish a causal relationship between glucagon-like peptide-1 (GLP-1) receptor agonists and suicidal behavior, suicidal ideation, self-injury and depression. 4 September 2024. 12 …
Pharma and Biotech News | The Pharmaletter
WEB4 days ago · Research shows migraine market to reach $16.4 billion by 2033. The global migraine market in mature economies is projected to grow from $9.2 billion in 2023 to $16.4 billion by 2033, according to a report from GlobalData. 10 September 2024. Biotechnology.
CROs keep growing, as Tigermed acquires Tokyo firm
WEBJul 31, 2024 · This article is accessible to registered users, to continue reading please register for free.. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the …
Login - The Pharmaletter
WEB4 days ago · The Pharma Letter. 39-43 Putney High Street, Putney London, SW15 1SP United Kingdom
Interviews with Pharma and Biotech Global Leaders
WEBJun 4, 2024 · The Pharma Letter Podcast — Episode 25 — The need for change for major depressive disorder patients. Welcome to The Pharma Letter Podcast for a promotional episode, sponsored by Janssen, where we will deep dive into barriers and challenges in treating major depressive disorder (MDD), and finish …
About The Pharma Letter | The Pharmaletter
WEB4 days ago · The Pharma Letter offers high value news and insights for people with a professional interest in the global pharmaceutical, biotech, generic and biosimilar industries. Headquartered in London, the company draws from a network of foreign correspondents, with healthcare journalists around the world providing insight on local markets.
Pharmaceutical Generics Industry News | The Pharmaletter
WEBMay 24, 2024 · Glenmark pays $25 million fine for generic price-fixing. Glenmark Pharmaceuticals has agreed to pay $25 million, based on its ability to pay, to resolve its alleged liability under the False Claims Act for conspiring to fix the price of a generic drug, the US Department of Justice announced. 5 September 2024.
Guy Martin - The Pharmaletter
WEB3 days ago · Guy Martin. Reporter The Pharma Letter. Guy Martin has been a journalist since 2008. He writes about all areas of pharma and biotech, and related business news. He has a special interest in emerging technologies leading to the development of personalized medicines, along with the changes this will bring to the pharmaceutical industry and beyond.
Kolon TissueGene cleared to resume US Phase III trial for Invossa
WEBApr 14, 2020 · The trial had been suspended due to product identity concerns, the company noted, adding that the firm’s US unit, Kolon TissueGene, has begun activities to resume the Phase III trial and reinitiate enrollment later this year. The clinical exploration was halted last May after Invossa’s cell line was found to have been mislabeled as ...